Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolismRobert Stöhr, Alexander Schuh, Dario Frank et al.|Clinical Cardiology|2022Cited by 6
Rivaroxaban versus vitamin K antagonist treatment on the progression of coronary calcification: the IRIVASC-trialRobert Stöhr, Vincent Brandenburg, Sebastian Reinartz et al.|Scientific Reports|2024Cited by 2